Last reviewed · How we verify
suspected recurrence based on elevated serum prostate-specific antigen (PSA) level
Approved treatments
- Posluma · Blue Earth
Posluma works by emitting radiation that helps doctors visualize and diagnose prostate cancer.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- suspected recurrence based on elevated serum prostate-specific antigen (PSA) level patent landscape — cliff calendar, originator estates, attackable patents
- suspected recurrence based on elevated serum prostate-specific antigen (PSA) level treatment landscape brief
- suspected recurrence based on elevated serum prostate-specific antigen (PSA) level treatment updates RSS
Frequently asked questions about suspected recurrence based on elevated serum prostate-specific antigen (PSA) level
What drugs treat suspected recurrence based on elevated serum prostate-specific antigen (PSA) level?
Tracked treatments include Posluma.
What is the treatment for suspected recurrence based on elevated serum prostate-specific antigen (PSA) level?
Standard treatment for suspected recurrence based on elevated serum prostate-specific antigen (PSA) level includes Posluma. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: suspected recurrence based on elevated serum prostate-specific antigen (PSA) level patent cliff · suspected recurrence based on elevated serum prostate-specific antigen (PSA) level CI report
- Treatment: Posluma · Blue Earth
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing